Study of FYU-981 in Hyperuricemia With or Without Gout

PHASE2CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

May 31, 2016

Study Completion Date

November 30, 2016

Conditions
Hyperuricemia
Interventions
DRUG

FYU-981

DRUG

Placebo

Trial Locations (1)

Unknown

Japan, Tokyo and Other Japanese City

Sponsors
All Listed Sponsors
lead

Fuji Yakuhin Co., Ltd.

INDUSTRY